| 1356 |
National Cancer Institute |
Html |
en |
Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of metastatic cancer that has spread from an unidentified primary tumor. |
| general cancer information | 0.411851 |
| treatment | 0.656267 |
| cancer treatment | 0.493001 |
| breast cancer cells | 0.486603 |
| primary cancer | 0.600191 |
| new cancer treatments | 0.408458 |
| Peritoneal Cancer Treatment | 0.426103 |
| cancer cells | 0.712358 |
| tissue | 0.443805 |
| malignant tumor cells | 0.423112 |
| body | 0.560831 |
| type | 0.447878 |
| Cancer Information Service | 0.414189 |
| Squamous Neck Cancer | 0.400297 |
| PDQ cancer information | 0.512966 |
| clinical trial search | 0.39505 |
| treatment clinical trials | 0.437756 |
| certain changes | 0.407705 |
| National Cancer Institute | 0.54586 |
| clinical trials | 0.823063 |
| normal cells | 0.410928 |
| cancer information summary | 0.471688 |
| clinical trial | 0.588388 |
| new treatment | 0.44726 |
|
| breast cancer prevention | 0.400005 |
| primary cancer site | 0.517081 |
| cancer tissue | 0.403216 |
| patients | 0.429603 |
| Cancer Care page | 0.397493 |
| PDQ summary | 0.435669 |
| treatment clinical trial | 0.401935 |
| PDQ Adult Treatment | 0.398071 |
| NCI PDQ cancer | 0.432436 |
| cancer research process | 0.400715 |
| cancer clinical trials | 0.44656 |
| tests | 0.388491 |
| lymph nodes | 0.409196 |
| Unknown Primary Treatment | 0.395812 |
| carcinoma | 0.39749 |
| primary cancer depend | 0.439856 |
| lymph node | 0.431668 |
| radiation therapy | 0.485838 |
| Treatment Editorial Board | 0.413559 |
| cancer information summaries | 0.411898 |
| comprehensive cancer information | 0.411754 |
| cancer | 0.945761 |
| standard treatment | 0.426236 |
|
CLICK HERE |
| 1675 |
National Cancer Institute |
Html |
en |
Lymphedema (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the anatomy, pathophysiology, clinical manifestations, diagnosis, and treatment of cancer-related lymphedema, a condition in which lymph fluid builds up in tissues and causes swelling. |
| upper-limb lymphedema | 0.596897 |
| Manual lymphatic therapy | 0.494091 |
| axillary node dissection | 0.485114 |
| lymph nodes. | 0.472628 |
| upper-extremity lymphedema | 0.68666 |
| arm lymphedema | 0.638618 |
| lower-limb lymphedema | 0.630542 |
| lymph node dissection | 0.832229 |
| lower-extremity lymphedema | 0.630897 |
| deep lymphatic systems | 0.498654 |
| intestinal lymphatic trunk | 0.501781 |
| new lymphedema | 0.619269 |
| lumbar lymphatic trunk | 0.502509 |
| upper extremity lymphedema | 0.623186 |
| manual lymphatic drainage | 0.477215 |
| lymph collector vessels | 0.497637 |
| lymphatic vessels | 0.762836 |
| lymphedema onset | 0.622585 |
| secondary lymphedema | 0.644407 |
| certified lymphedema | 0.696216 |
| left subclavian vein | 0.475686 |
| lymphedema manifest | 0.633761 |
| lymphedema classification | 0.594846 |
| protein-rich lymph fluid | 0.533977 |
|
| secondary lymphatic vessels | 0.59679 |
| subclavian lymphatic trunk | 0.576658 |
| primary lymphatic vessels | 0.596665 |
| subcutaneous lymphatic vessels | 0.50703 |
| lymphedema | 0.987634 |
| breast cancer patients | 0.473019 |
| certified lymphedema therapist | 0.652056 |
| patients | 0.478875 |
| cancer patients | 0.474035 |
| Lymph channels | 0.46738 |
| lymph node biopsy | 0.634545 |
| breast cancer | 0.848001 |
| sentinel lymph node | 0.728941 |
| certified lymphedema therapists | 0.649954 |
| unidirectional lymphatic flow | 0.496065 |
| breast cancer survivors | 0.505056 |
| axillary lymph node | 0.799687 |
| lymph nodes | 0.59192 |
| treatable lymphedema | 0.590609 |
| lymph node biopsy. | 0.539242 |
| manual lymphedema therapy. | 0.64813 |
| lymph node drainage | 0.539621 |
| manual lymphedema therapy | 0.852751 |
|
CLICK HERE |
| 1765 |
National Cancer Institute |
Html |
en |
Physical Activity and Cancer |
A fact sheet that summarizes evidence linking exercise and other physical activity, including work and household chores, to reduced cancer risks. |
| U. Physical activity | 0.367372 |
| bone-strengthening physical activity | 0.370971 |
| physical activity daily | 0.371076 |
| physical activity attenuate | 0.362897 |
| better breast cancer | 0.3594 |
| low physical activity | 0.37763 |
| Breast Cancer Research | 0.357155 |
| muscle-strengthening physical activity | 0.370998 |
| vigorous physical activity | 0.364437 |
| S. Physical activity | 0.365821 |
| average breast cancer | 0.365315 |
| cancer risk reduction | 0.373439 |
| colorectal cancer | 0.41572 |
| average endometrial cancer | 0.357301 |
| H. Physical activity | 0.366033 |
| postdiagnosis physical activity | 0.363749 |
| postmenopausal breast cancer | 0.379275 |
| lower risk | 0.357009 |
| potential physical activity | 0.369413 |
| physical activity influence | 0.360893 |
| different cancer risk | 0.360424 |
| aerobic physical activity | 0.386234 |
| vigorous-intensity physical activity | 0.373987 |
| cancer survivors | 0.406644 |
| Cancer Epidemiology | 0.363652 |
|
| cancer prevention | 0.376861 |
| Physical Activity website | 0.371276 |
| A. Physical activity | 0.364619 |
| breast cancer diagnosis | 0.4205 |
| endometrial cancer risk | 0.390992 |
| breast cancer recurrence | 0.359315 |
| Physical Activity Guidelines | 0.371598 |
| links physical activity | 0.369787 |
| physical activity benefit | 0.375758 |
| National Cancer Institute | 0.363045 |
| daily physical activity | 0.370902 |
| L. Physical activity | 0.366831 |
| breast cancer risk | 0.390634 |
| colon cancer | 0.375643 |
| meta-analysis | 0.376142 |
| breast cancer | 0.54813 |
| colon cancer risk | 0.372667 |
| systematic review | 0.435657 |
| physical activity | 0.996162 |
| prostate cancer | 0.369869 |
| leisure-time physical activity | 0.442557 |
| et al | 0.539243 |
| cancer risk | 0.441434 |
| recreational physical activity | 0.391568 |
|
CLICK HERE |
| 1838 |
National Cancer Institute |
Html |
es |
Tratamiento del cáncer de testículo (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento del cáncer de testículo. |
| Warde P | 0.218827 |
| Compton CC | 0.2177 |
| Belt-Dusebout AW | 0.219564 |
| Cancer Collaborative Group | 0.22935 |
| Fosså SD | 0.255716 |
| germ cell tumor | 0.301479 |
| testicular cancer | 0.813967 |
| Sin embargo | 0.218866 |
| 7th ed | 0.217529 |
| germ cell tumours | 0.262155 |
| Cell Cancer Collaborative | 0.240371 |
| cell testicular tumors | 0.220056 |
| testicular malignant germ | 0.217591 |
| tumor markers | 0.216572 |
| International Germ Cell | 0.302822 |
| Natl Cancer Inst | 0.334587 |
| second cancers | 0.223863 |
| contralateral testicular germ | 0.218168 |
| cell tumor patients | 0.216601 |
| Testicular Cancer Study | 0.224272 |
| patients with | 0.222118 |
| testicular intraepithelial neoplasia | 0.225067 |
| with testicular germ | 0.235317 |
| Eur Urol | 0.215174 |
| Urol Clin North | 0.219868 |
|
| testicular seminoma | 0.246035 |
| Germ Cell Consensus | 0.24481 |
| Cell Cancer Consensus | 0.272426 |
| >2 cm | 0.228724 |
| Cancer Staging Manual | 0.263147 |
| European Germ Cell | 0.228106 |
| germ cell | 0.993431 |
| nonseminomatous germ | 0.23506 |
| cicatriz histológica testicular | 0.215529 |
| Clin Oncol | 0.466287 |
| saco vitelino | 0.231013 |
| Clin North Am | 0.217469 |
| estadio iii | 0.231852 |
| clinical stage | 0.215125 |
| Cell Consensus Classification | 0.239173 |
| Byrd DR | 0.216367 |
| testicular germ-cell tumours | 0.215172 |
| cancer consensus group | 0.233559 |
| germ cell testis | 0.214767 |
| germ cell cancer | 0.692466 |
| Children's Cancer Study | 0.215431 |
| testicular germ | 0.280501 |
| Cancer Study Group | 0.229234 |
| AJCC Cancer Staging | 0.265329 |
|
CLICK HERE |
| 2068 |
National Cancer Institute |
Html |
es |
Marcadores de tumores |
Hoja informativa que explica lo que son los marcadores de tumores y responde preguntas sobre su uso para el diagnóstico y tratamiento del cáncer. |
| Bast RC Jr | 0.727949 |
| cancer screening | 0.603977 |
| Gray RJ | 0.462067 |
| randomized european study | 0.51305 |
| Asociación Estadounidense | 0.468124 |
| estudio plco | 0.461327 |
| Bigbee W | 0.467579 |
| amplia gama | 0.464843 |
| afecciones benignas | 0.671952 |
| Herberman RB | 0.469893 |
| Prevention Research | 0.463207 |
| BC Decker Inc | 0.509079 |
| Clinical Laboratory Improvement | 0.519898 |
| Cancer Screening Randomized | 0.544857 |
| Controlled Trial | 0.467216 |
| riesgo intermedio | 0.462476 |
| Clinical Practice | 0.47196 |
| ecografÃa transvaginal | 0.471751 |
| Makower DF | 0.466396 |
| estudio tailorx | 0.460805 |
| ¿Cuáles marcadores | 0.637902 |
| 21-gene expression assay | 0.514014 |
|
| Hugosson J | 0.463892 |
| Instituto Nacional | 0.461324 |
| screening trial specimens | 0.541412 |
| OncologÃa ClÃnica | 0.463202 |
| tumor markers | 0.619108 |
| Andriole G | 0.463781 |
| Mortality results from | 0.526447 |
| Quality Requirements | 0.470424 |
| Kufe DW | 0.468535 |
| Black A | 0.461077 |
| 6th ed | 0.467056 |
| Oncotype DX® | 0.469566 |
| situaciones benignas | 0.492829 |
| PubMed Abstract | 0.928354 |
| tratamientos resultantes | 0.466203 |
| Buys SS | 0.460749 |
| BioquÃmica ClÃnica | 0.461341 |
| Pollock RE | 0.46616 |
| New England Journal | 0.930005 |
| Roobol MJ | 0.466517 |
| Sparano JA | 0.466154 |
| hoja informativa estadificación | 0.539118 |
|
CLICK HERE |
| 2973 |
National Cancer Institute |
Video |
en |
Make Sure You Have What It Takes |
Ready to quit smoking? Make sure you have what it takes. Visit teen.smokefree.gov. |
| 02 | 0.414634 |
| ElixirMediaProd | 0.414568 |
| CDC | 0.732439 |
| QuitSmokingCom | 0.418054 |
| Sperm | 0.414461 |
| Famous People | 0.497717 |
| body | 0.415775 |
| Anti Smoking Commercial | 0.594002 |
| Disease Control | 0.79595 |
| Michael | 0.432529 |
| List | 0.414915 |
| Belhus | 0.420781 |
| Story | 0.414456 |
| Ellie | 0.41667 |
| Smokers | 0.569726 |
| Asthma Attack | 0.474832 |
| Duration | 0.939681 |
| Home Alchemy | 0.475983 |
| Hollywood | 0.417592 |
| mutation | 0.414755 |
| Smoking Advice | 0.525781 |
| Men | 0.414403 |
| Unattractive Things | 0.479984 |
| basement | 0.414589 |
|
| Smoking Timeline | 0.544895 |
| Centers | 0.483728 |
| NHS Smokefree | 0.484439 |
| Allen Carr | 0.481427 |
| Unkle Adams | 0.494687 |
| Losers Game | 0.480152 |
| air | 0.41576 |
| Aadarsh Sharma | 0.493771 |
| Videos | 0.414563 |
| Prevention | 0.483581 |
| Chicken Egg | 0.47424 |
| Great Ads | 0.480844 |
| smoking | 0.667373 |
| Smoking PSA | 0.536443 |
| views | 0.800457 |
| Terrifying | 0.418131 |
| CDC Tips | 0.549794 |
| James | 0.414466 |
| Domonic Smith | 0.486979 |
| Quit Smoking | 0.543911 |
| COPD patient | 0.483677 |
| Olly | 0.42117 |
| Planet Nibiru | 0.480348 |
| Doritos Commercial Compilation | 0.548737 |
|
CLICK HERE |
| 3582 |
National Cancer Institute |
Html |
en |
Frederick National Laboratory for Cancer Research |
The FNLCR combines private sector business practices with government infrastructure to conduct research and development in cancer and AIDS. |
| Frederick National Lab | 0.679634 |
| Development Center—one | 0.586036 |
| Federally Funded Research | 0.723777 |
| FNLCR | 0.617129 |
| biomarker identification | 0.53533 |
| animal sciences | 0.53568 |
| national resource | 0.541398 |
| government agencies | 0.530109 |
| human clinical trials | 0.61809 |
| preclinical assay development | 0.712354 |
| oncology-focused computational science | 0.628628 |
| cancer research laboratories | 0.757218 |
| early development | 0.553877 |
| research reagents | 0.571396 |
| NCI | 0.666268 |
| genetically engineered mouse | 0.603734 |
| preclinical research | 0.638044 |
| nonprofit research organizations | 0.690454 |
| broad charter | 0.538883 |
| Leidos Biomedical Research | 0.735212 |
| United States | 0.647036 |
| Nanotechnology Characterization Laboratory | 0.625355 |
| RAS family | 0.527528 |
| clinical practice | 0.533965 |
|
| NCI investigators | 0.632716 |
| significant cancer research | 0.722685 |
| translational genomics | 0.544933 |
| cancer research | 0.952491 |
| private sector business | 0.653242 |
| new drug development | 0.647375 |
| government sponsors | 0.545164 |
| biomedical research community | 0.670235 |
| development needs | 0.584975 |
| cancer researchers | 0.562687 |
| clinical operations | 0.542191 |
| Frederick National Laboratory | 0.684108 |
| government infrastructure | 0.535486 |
| technical staff | 0.530406 |
| preclinical model development | 0.704349 |
| private sector resources | 0.635668 |
| FNLCR programs | 0.564698 |
| National lab staff | 0.628876 |
| biomedical computing | 0.548325 |
| new cancer therapies | 0.637914 |
| frozen tumor samples | 0.605424 |
| nanotechnology applications | 0.53469 |
| cancer research enterprise | 0.705608 |
| basic research | 0.59861 |
|
CLICK HERE |
| 4330 |
National Cancer Institute |
Html |
en |
Screening Tests |
Information about tests that may be used to screen for cancer in people without symptoms of disease. |
| Breast Cancer Screening | 0.406484 |
| health care provider | 0.30932 |
| expert groups | 0.265652 |
| Cancer Screening summary | 0.902327 |
| fact sheet | 0.466524 |
| occult blood tests | 0.269438 |
| Mammograms fact sheet | 0.267038 |
| Detect Colorectal Cancer | 0.350233 |
| Prostate Cancer Screening | 0.306727 |
| health care providers | 0.256913 |
| PDQ® Breast Cancer | 0.380619 |
| Cancer Risk | 0.261618 |
| transvaginal ultrasound | 0.266045 |
| Ovarian Cancer Screening | 0.355679 |
| colorectal cancer | 0.408815 |
| routine PSA testing | 0.258642 |
| test | 0.313731 |
| Genetic Testing fact | 0.262194 |
| Skin Cancer Screening | 0.305113 |
| heavy smokers ages | 0.262129 |
| Colorectal Cancer Screening | 0.370971 |
| high risk | 0.258361 |
| Testing fact sheet | 0.311925 |
| Endometrial Cancer Screening | 0.308488 |
|
| Breast MRI | 0.244315 |
| Cervical Cancer Screening | 0.31686 |
| women | 0.251835 |
| imaging test | 0.262647 |
| digital rectal exam | 0.25607 |
| prostate cancer deaths | 0.288964 |
| helical computed tomography | 0.266342 |
| Clinical breast exams | 0.268026 |
| PDQ® Colorectal Cancer | 0.346246 |
| HPV Testing fact | 0.264281 |
| Polyps fact sheet | 0.318987 |
| effective ovarian cancer | 0.290042 |
| Lung Cancer Screening | 0.320215 |
| regular breast self-exams | 0.270315 |
| Melanoma fact sheet | 0.258634 |
| National Lung Screening | 0.295693 |
| Alpha-fetoprotein blood test | 0.268207 |
| PDQ® Ovarian Cancer | 0.331871 |
| blood test | 0.291254 |
| lung cancer deaths | 0.300295 |
| Test fact sheet | 0.267108 |
| information | 0.299153 |
| risk | 0.28214 |
| liver cancer | 0.25618 |
|
CLICK HERE |
| 4389 |
National Cancer Institute |
Html |
en |
Sunlight |
Exposure to UV radiation from the sun, sunlamps, and tanning booths causes early aging and skin damage that can lead to skin cancer. Find information, including tips, on how to protect your skin. |
| skin cancer | 0.670141 |
| sun visors | 0.456822 |
| shades | 0.330644 |
| early aging | 0.476035 |
| dark skin | 0.458278 |
| sources | 0.329654 |
| skin damage | 0.480277 |
| wide brim | 0.466856 |
| windshields | 0.391235 |
| mid-morning | 0.329734 |
| long pants | 0.452301 |
| skin | 0.754109 |
| SPF | 0.373931 |
| ice | 0.356895 |
| UPF | 0.341366 |
| clouds | 0.329163 |
| skin tones | 0.597399 |
| tips | 0.329364 |
| Wear sunglasses | 0.448638 |
| sun protection factor | 0.555629 |
| dark fabrics | 0.445529 |
| light skin tone | 0.592307 |
| hat | 0.32822 |
|
| pavement | 0.327954 |
| mind | 0.357411 |
| late afternoon | 0.469796 |
| light clothing | 0.439637 |
| Exposure | 0.331467 |
| sunscreen products | 0.456996 |
| windows | 0.357118 |
| neck | 0.328307 |
| people | 0.384721 |
| water | 0.356986 |
| UV radiation | 0.940101 |
| sand | 0.362057 |
| sunlight | 0.380409 |
| ultraviolet protection factor | 0.576115 |
| snow | 0.359149 |
| booths | 0.335732 |
| parts | 0.327951 |
| ages | 0.329914 |
| sunlamps | 0.332236 |
| time | 0.329824 |
| beds | 0.330757 |
| rays | 0.330102 |
|
CLICK HERE |
| 16886 |
National Cancer Institute |
Html |
en |
Thyroid Cancer Screening (PDQ®)–Health Professional Version |
Expert-reviewed information summary about tests used to detect or screen for thyroid cancer. |
| thyroid cancer trends | 0.476323 |
| thyroid tumors | 0.422645 |
| United States | 0.468063 |
| thyroid cancer screening. | 0.46539 |
| cancer registry data | 0.363099 |
| thyroid fine-needle aspiration | 0.447959 |
| opportunistic thyroid cancer | 0.46743 |
| thyroid cancer | 0.931034 |
| thyroid cancer incidence | 0.631162 |
| Thyroid Cancer Treatment | 0.500772 |
| Well-differentiated thyroid cancers | 0.495048 |
| palpation screening results | 0.370878 |
| total thyroidectomy | 0.358528 |
| cancer screening results | 0.386186 |
| radioactive iodine | 0.350234 |
| South Korea | 0.456219 |
| 10-year relative survival | 0.451331 |
| frequently diagnosed cancer | 0.37852 |
| recurrent laryngeal nerve | 0.36801 |
| papillary thyroid cancer | 0.525506 |
| summary event measure | 0.364067 |
| free screening exams | 0.364504 |
| follicular thyroid cancers | 0.495803 |
| thyroid cancer mortality | 0.490522 |
|
| thyroid cancer overdiagnosis | 0.479797 |
| neck palpation | 0.364787 |
| cancer incidence rates | 0.389027 |
| thyroid cancer deaths. | 0.489306 |
| thyroid cancers cases | 0.461202 |
| thyroid cancer cases | 0.467037 |
| papillary thyroid cancers | 0.524728 |
| cancer diagnoses | 0.354076 |
| anaplastic thyroid cancers | 0.495303 |
| laryngeal nerve injury | 0.368292 |
| thyroid cancer screening | 0.828908 |
| thyroid cancers | 0.597668 |
| thyroid ultrasound | 0.428817 |
| suspicious screening result | 0.361018 |
| thyroid surgery | 0.435882 |
| population-based screening programs | 0.366887 |
| national cancer screening | 0.412147 |
| medullary thyroid cancer | 0.491568 |
| Cancer Screening Guidelines | 0.39228 |
| formal screening | 0.347128 |
| asymptomatic thyroid cancers | 0.481523 |
| incidental thyroid nodules | 0.466527 |
| vocal cord | 0.353855 |
|
CLICK HERE |